Moderna, Inc. (MRNA) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 82.29B USD. 52-week range 22.28 to 212.22 USD. Data as of 2026-10-09.
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial ...